REGENXBIO
RGNX
S$10.83
Share price
-4.32%
Change (1 day)
-43.77%
Change (1 year)
Categories
REGENXBIO (RGNX) - Total liabilities
Total liabilities on the balance sheet as of March 2025 : S$0.27 Billion
According to REGENXBIO's latest financial reports the company's total liabilities are S$0.27 Billion. A company’s total liabilities is the sum of all current and non-current debts and obligations.
REGENXBIO - Total liabilities on balance sheet (from 2014 to 2025)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2024-12-31 | S$0.28 B | -19.02% |
| 2023-12-31 | S$0.34 B | -18.52% |
| 2022-12-31 | S$0.42 B | -10.06% |
| 2021-12-31 | S$0.47 B | 8.13% |
| 2020-12-31 | S$0.43 B | 579.56% |
| 2019-12-31 | S$64.32 M | 34.65% |
| 2018-12-31 | S$47.76 M | 128.24% |
| 2017-12-31 | S$20.92 M | 31.52% |
| 2016-12-31 | S$15.91 M | 146.06% |
| 2015-12-31 | S$6.46 M | -46.74% |
| 2014-12-31 | S$12.14 M | 105.96% |
| 2013-12-31 | S$5.89 M |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | S$29.76 M | -89.33% | 🇺🇸 USA |